COVESTRO AG (1COV.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:1COV - DE0006062144 - Common Stock
59.98 EUR
+0.18 (+0.3%)
Taking everything into account, 1COV scores 2 out of 10 in our fundamental rating. 1COV was compared to 68 industry peers in the Chemicals industry. 1COV has a bad profitability rating. Also its financial health evaluation is rather negative. 1COV does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
1COV had negative earnings in the past year.
In the past year 1COV had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: 1COV reported negative net income in multiple years.
1COV had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of -3.46%, 1COV is doing worse than 77.94% of the companies in the same industry.
The Return On Equity of 1COV (-7.52%) is worse than 79.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.46% | ||
| ROE | -7.52% | ||
| ROIC | N/A |
ROA(3y)-1.76%
ROA(5y)1.73%
ROE(3y)-3.61%
ROE(5y)3.67%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
1COV's Operating Margin has declined in the last couple of years.
1COV has a Gross Margin of 13.93%. This is in the lower half of the industry: 1COV underperforms 79.41% of its industry peers.
In the last couple of years the Gross Margin of 1COV has declined.
1COV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 13.93% |
OM growth 3Y-78.51%
OM growth 5Y-54.06%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18%
GM growth 5Y-7.1%
2. Health
2.1 Basic Checks
1COV does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 1COV remains at a similar level compared to 1 year ago.
Compared to 5 years ago, 1COV has more shares outstanding
Compared to 1 year ago, 1COV has an improved debt to assets ratio.
2.2 Solvency
1COV has an Altman-Z score of 2.27. This is not the best score and indicates that 1COV is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.27, 1COV perfoms like the industry average, outperforming 44.12% of the companies in the same industry.
1COV has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
1COV has a Debt to Equity ratio of 0.34. This is comparable to the rest of the industry: 1COV outperforms 58.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.27 |
ROIC/WACCN/A
WACC6.37%
2.3 Liquidity
1COV has a Current Ratio of 1.36. This is a normal value and indicates that 1COV is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.36, 1COV is not doing good in the industry: 76.47% of the companies in the same industry are doing better.
1COV has a Quick Ratio of 1.36. This is a bad value and indicates that 1COV is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.73, 1COV is doing worse than 77.94% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.36 | ||
| Quick Ratio | 0.73 |
3. Growth
3.1 Past
1COV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -76.09%.
Looking at the last year, 1COV shows a decrease in Revenue. The Revenue has decreased by -5.27% in the last year.
Measured over the past years, 1COV shows a small growth in Revenue. The Revenue has been growing by 2.70% on average per year.
EPS 1Y (TTM)-76.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-247.06%
Revenue 1Y (TTM)-5.27%
Revenue growth 3Y-3.75%
Revenue growth 5Y2.7%
Sales Q2Q%-11.99%
3.2 Future
1COV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.37% yearly.
The Revenue is expected to grow by 1.10% on average over the next years.
EPS Next Y-40.99%
EPS Next 2Y53.83%
EPS Next 3Y43.15%
EPS Next 5Y20.37%
Revenue Next Year-7.78%
Revenue Next 2Y-2.6%
Revenue Next 3Y-0.49%
Revenue Next 5Y1.1%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
1COV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 115.30, 1COV can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, 1COV is valued a bit more expensive than 72.06% of the companies in the same industry.
1COV's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 115.3 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, 1COV is valued a bit more expensive than the industry average as 69.12% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 17 |
4.3 Compensation for Growth
A more expensive valuation may be justified as 1COV's earnings are expected to grow with 43.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.83%
EPS Next 3Y43.15%
5. Dividend
5.1 Amount
No dividends for 1COV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
FRA:1COV (12/22/2025, 7:00:00 PM)
59.98
+0.18 (+0.3%)
Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners23.42%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap11.34B
Revenue(TTM)13.40B
Net Income(TTM)-458.00M
Analysts49.47
Price Target62.53 (4.25%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly Dividend0.01
Dividend Growth(5Y)-70.61%
DP-0.22%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-69.67%
Min EPS beat(2)-139.31%
Max EPS beat(2)-0.04%
EPS beat(4)0
Avg EPS beat(4)-380.46%
Min EPS beat(4)-1222.75%
Max EPS beat(4)-0.04%
EPS beat(8)1
Avg EPS beat(8)-4244%
EPS beat(12)2
Avg EPS beat(12)-2876.36%
EPS beat(16)3
Avg EPS beat(16)-2162.14%
Revenue beat(2)0
Avg Revenue beat(2)-4.63%
Min Revenue beat(2)-6.91%
Max Revenue beat(2)-2.34%
Revenue beat(4)0
Avg Revenue beat(4)-4.71%
Min Revenue beat(4)-6.91%
Max Revenue beat(4)-2.34%
Revenue beat(8)0
Avg Revenue beat(8)-4.43%
Revenue beat(12)0
Avg Revenue beat(12)-4.49%
Revenue beat(16)3
Avg Revenue beat(16)-2.5%
PT rev (1m)0.82%
PT rev (3m)0.72%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.02%
EPS NY rev (1m)-6.62%
EPS NY rev (3m)-31.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.71%
Revenue NY rev (1m)-0.33%
Revenue NY rev (3m)-3.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 115.3 | ||
| P/S | 0.85 | ||
| P/FCF | N/A | ||
| P/OCF | 14.21 | ||
| P/B | 1.86 | ||
| P/tB | 2.29 | ||
| EV/EBITDA | 17 |
EPS(TTM)-2.43
EYN/A
EPS(NY)0.52
Fwd EY0.87%
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)4.22
OCFY7.04%
SpS70.92
BVpS32.22
TBVpS26.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.46% | ||
| ROE | -7.52% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 13.93% | ||
| FCFM | N/A |
ROA(3y)-1.76%
ROA(5y)1.73%
ROE(3y)-3.61%
ROE(5y)3.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.42%
ROCE(5y)6.03%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-78.51%
OM growth 5Y-54.06%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18%
GM growth 5Y-7.1%
F-Score3
Asset Turnover1.01
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.34 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.47 | ||
| Cap/Depr | 92.05% | ||
| Cap/Sales | 6.83% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 95% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.36 | ||
| Quick Ratio | 0.73 | ||
| Altman-Z | 2.27 |
F-Score3
WACC6.37%
ROIC/WACCN/A
Cap/Depr(3y)75.52%
Cap/Depr(5y)82.02%
Cap/Sales(3y)5.15%
Cap/Sales(5y)5.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-247.06%
EPS Next Y-40.99%
EPS Next 2Y53.83%
EPS Next 3Y43.15%
EPS Next 5Y20.37%
Revenue 1Y (TTM)-5.27%
Revenue growth 3Y-3.75%
Revenue growth 5Y2.7%
Sales Q2Q%-11.99%
Revenue Next Year-7.78%
Revenue Next 2Y-2.6%
Revenue Next 3Y-0.49%
Revenue Next 5Y1.1%
EBIT growth 1Y-220.31%
EBIT growth 3Y-79.32%
EBIT growth 5Y-52.83%
EBIT Next Year238.79%
EBIT Next 3Y78.95%
EBIT Next 5Y42.34%
FCF growth 1Y-116.5%
FCF growth 3Y-60.36%
FCF growth 5Y-28.37%
OCF growth 1Y-45.3%
OCF growth 3Y-26.52%
OCF growth 5Y-8.84%
COVESTRO AG / 1COV.DE FAQ
What is the fundamental rating for 1COV stock?
ChartMill assigns a fundamental rating of 2 / 10 to 1COV.DE.
What is the valuation status of COVESTRO AG (1COV.DE) stock?
ChartMill assigns a valuation rating of 1 / 10 to COVESTRO AG (1COV.DE). This can be considered as Overvalued.
Can you provide the profitability details for COVESTRO AG?
COVESTRO AG (1COV.DE) has a profitability rating of 1 / 10.
How financially healthy is COVESTRO AG?
The financial health rating of COVESTRO AG (1COV.DE) is 3 / 10.